orange cnty tr - OBT
OBT
Close Chg Chg %
34.07 1.14 3.35%
Closed Market
35.21
+1.14 (3.35%)
Volume: 101.75K
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: orange cnty tr - OBT
OBT Key Data
| Open $34.61 | Day Range 34.05 - 35.43 |
| 52 Week Range 20.97 - 35.43 | Market Cap $435.22M |
| Shares Outstanding 13.37M | Public Float 11.20M |
| Beta 0.45 | Rev. Per Employee N/A |
| P/E Ratio 10.24 | EPS $3.32 |
| Yield 167.30% | Dividend $0.18 |
| EX-DIVIDEND DATE Dec 4, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 47.76K |
OBT Performance
| 1 Week | 14.24% | ||
| 1 Month | 21.67% | ||
| 3 Months | 33.73% | ||
| 1 Year | 30.65% | ||
| 5 Years | 151.50% |
OBT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 31.333 | |
| Number of Ratings | 3 | Current Quarters Estimate | 0.753 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 3.223 | |
| Last Quarter’s Earnings | 0.93 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.831 | Next Fiscal Year Estimate | 3.643 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | 0.75 | 0.79 | 3.22 | 3.64 |
| High Estimates | 0.82 | 0.84 | 3.45 | 3.90 |
| Low Estimate | 0.66 | 0.73 | 2.90 | 3.25 |
| Coefficient of Variance | 11.05 | 7.17 | 8.92 | 9.49 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Orange Cnty Tr - OBT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Orange Cnty Tr - OBT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 19, 2025 | Michael Lesler EVP, Chief Financial Officer | 12,605 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $28.95 per share | 364,914.75 |
| Dec 19, 2025 | Michael Lesler EVP, Chief Financial Officer | 902 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | Gregory Sousa EVP and Deputy CLO | 3,682 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | Marie A. Holcombe Director | 22,198 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | Marianna R. Kennedy Director | 8,647 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | Richard B. Rowley Director | 22,816 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | Jonathan F. Rouis Director | 5,873 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 18, 2025 | William D. Morrison Director | 1,143 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 18, 2025 | Jonathan Schiller Director | 2,276 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 19, 2025 | Gregory F. Holcombe Director | 20,257 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 19, 2025 | Olga Luz Tirado Director | 99 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 19, 2025 | Kevin J. Keane Director | 13,992 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 19, 2025 | Michael J. Gilfeather President and CEO; Director | 21,810 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 6, 2025 | Jonathan Schiller Director | 12,446 | Open market or private purchase of non-derivative security Non-derivative transaction at $23.25 per share | 289,369.50 |
| Apr 4, 2025 | Marie A. Holcombe Director | 20,144 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Stephen F. Rooney SVP, Chief Credit Officer | 9,468 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | William D. Morrison Director | 102,639 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 25, 2025 | Marie A. Holcombe Director | 68,953 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 25, 2025 | David P. Dineen SVP, Dir. Wealth Services | 9,866 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Michael J. Gilfeather President and CEO; Director | 108,294 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |